Non-Coeliac Gluten Sensitivity: Prevalence & Lack of Markers
“`html
Non-Celiac Gluten/Wheat Sensitivity: A global Prevalence and Understanding
Table of Contents
What is Non-Celiac Gluten/Wheat Sensitivity (NCGWS)?
Approximately one in ten peopel globally experience gastrointestinal symptoms – alongside fatigue and headaches – after consuming gluten or wheat, despite testing negative for coeliac disease and wheat allergy. This condition is known as non-coeliac gluten/wheat sensitivity (NCGWS). A large systematic review and meta-analysis published in gut details these findings, highlighting the growing recognition of this often-misunderstood condition. Source: Gut
Prevalence and Demographics
The systematic review and meta-analysis, encompassing 25 studies and 49,476 participants across 16 countries, provides the most thorough data to date on NCGWS prevalence.The research, conducted between 2014 and 2024, reveals a significant global impact. While precise numbers vary between studies, the consistent finding is a substantial proportion of the population reporting symptoms suggestive of NCGWS.
NCGWS appears to be more prevalent in women than in men, and is frequently associated with other conditions like Irritable bowel Syndrome (IBS), anxiety, and depression. The correlation with these conditions suggests a complex interplay between gut health, mental wellbeing, and dietary sensitivities.
| region | Estimated Prevalence Range (Self-Reported) | Study Sample Size (Approximate) |
|---|---|---|
| Europe | 6% – 12% | 15,000+ |
| North America | 8% – 10% | 12,000+ |
| Asia | 4% – 8% | 10,000+ |
| Australia | 7% – 9% | 5,000+ |
| South America | 5% – 7% | 7,000+ |
Note: Prevalence ranges are based on aggregated data from the included studies and may vary. Sample sizes are approximate.
Symptoms and Diagnosis
Individuals with NCGWS typically experience symptom betterment when gluten or wheat is removed from their diet, and symptom recurrence upon reintroduction. Common symptoms include bloating, abdominal pain, diarrhea, fatigue, headache, and brain fog. However, unlike coeliac disease and wheat allergy, NCGWS lacks specific biomarkers for diagnosis.
Currently, diagnosis